Research suggests that oral glutathione supplementation may help increase insulin sensitivity in individuals with and without type-2 diabetes
Sterility Microbial contamination testing per USP standards
The conditions that have been associated with glutathione deficiency include the following: Neurodegenerative diseases such as Alzheimers, Parkinsons and Huntingtons disease and ALS Pulmonary diseases such as COPD, asthma, and acute respiratory distress syndrome Immune system disorders Cardiovascular diseases such as high blood pressure, elevated cholesterol, and heart attacks Chronic age-related disorders such as cataracts, macular degeneration, hearing impairment, and glaucoma Liver disease Cystic fibrosis Aging processes (Pizzorno, 2014)
The early decline phase (weeks 2-8) marks when users first notice subtle changes as copper levels normalize to dietary intake baseline, collagen synthesis rates decline toward pre-treatment levels, and the balance between new collagen production and ongoing degradation shifts toward net neutral or slight decline
GHK-Cu addresses the same underlying process at the molecular level, by restoring one of the bodys own signaling molecules rather than physically injuring tissue to force a repair response
These requirements address identity, purity, strength, composition and limits on contamination
